EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Progress and Prospects of Nanodelivery Systems in Metabolism‐Regulated mRNA Vaccines

Wanqing Wang iD, Hao Zhang, Shujuan Ren, Ruonan Li, Jie Chen, Beining Zhang, Jiaxin Wang, Cuiping Li, Xinrui Gao, Yaling Tian, Zhaowei Sun, Qiang Ma iD und 1 weitere

Biotechnology Journal · 2026-07 · 21 (7)

DOI: 10.1002/biot.70278 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biotechnology Journal, online erschienen am 09.07.2026. Verfasst von Wanqing Wang und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Zhengzhou University, Zhengzhou, China. Hauptthemen laut MEDLINE: Cancer Vaccines, Neoplasms, mRNA Vaccines, Drug Delivery Systems. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 166 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

mRNA vaccines face two major challenges in tumor immunotherapy: inefficient delivery and an immunosuppressive tumor microenvironment (TME) driven by metabolic reprogramming. This review proposes that nanodelivery systems can overcome both obstacles by protecting and targeting mRNA while simultaneously reshaping tumor metabolism and immunity. We summarize how nanocarriers act as “metabolism‐immunity dual regulation centers” through three mechanisms: co‐delivery of metabolic regulators, intrinsic modulation of immune cell metabolism via material properties, and TME‐responsive spatiotemporal release. We further emphasize the central roles of the mTOR/STAT3/HIF‐1α signaling axes in linking metabolic dysregulation to immune suppression and compare the metabolic adaptability of major nanocarrier platforms. Finally, we discuss rational design principles, validation strategies, clinical translation barriers, and future directions, including AI‐assisted design and engineered live carriers. This review provides an integrated framework for developing next‐generation antitumor mRNA vaccines. The proposed “metabolism‐immunity dual regulation” strategy combines efficient delivery, metabolic reprogramming, and durable immune activation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer VaccinesNeoplasmsmRNA VaccinesDrug Delivery SystemsRNA, MessengerNanoparticle Drug Delivery SystemHumansTumor MicroenvironmentAnimalsImmunotherapyNanoparticlesMetabolic Reprogramming

Stichwörter der Autor:innen

cancer immunotherapyimmune activationmRNA vaccinemetabolic regulationnanocarriertumor microenvironmentvaccine delivery

Substanzen

Cancer VaccinesmRNA VaccinesRNA, MessengerNanoparticle Drug Delivery System

Autor:innen und Institutionen

  • School of Life Sciences, Zhengzhou University, Zhengzhou, China.

ORCID-Profile: Wanqing Wang, Qiang Ma

Zitieren

APA

Wang, W., Zhang, H., Ren, S., Li, R., Chen, J., Zhang, B., Wang, J., Li, C., Gao, X., Tian, Y., Sun, Z., Ma, Q., & Weng, H. (2026). Progress and Prospects of Nanodelivery Systems in Metabolism‐Regulated mRNA Vaccines. Biotechnology Journal, 21(7). https://doi.org/10.1002/biot.70278

Vancouver

Wang W, Zhang H, Ren S, Li R, Chen J, Zhang B, et al. Progress and Prospects of Nanodelivery Systems in Metabolism‐Regulated mRNA Vaccines. Biotechnology Journal. 2026;21(7). doi:10.1002/biot.70278

BibTeX
@article{Wang2026,
  author = {Wang, Wanqing and Zhang, Hao and Ren, Shujuan and Li, Ruonan and Chen, Jie and Zhang, Beining and Wang, Jiaxin and Li, Cuiping and Gao, Xinrui and Tian, Yaling and Sun, Zhaowei and Ma, Qiang and Weng, Haibo},
  title = {Progress and Prospects of Nanodelivery Systems in Metabolism‐Regulated mRNA Vaccines},
  journal = {Biotechnology Journal},
  year = {2026},
  volume = {21},
  number = {7},
  doi = {10.1002/biot.70278}
}
Kostenlos starten →